You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

adult desmoplastic small round cell tumor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tumor, Desmoplastic Small Round Cell, Adult, Tumor, Desmoplastic Small Round Cell, Childhood, Sarcoma, Ewing Trial in Spain (nab

Completed
  • Tumor, Desmoplastic Small Round Cell, Adult
  • +4 more
  • nab paclitaxel
  • Barcelona, Spain
  • +6 more
Jun 6, 2022

Adult Alveolar Soft Part Sarcoma, Adult Angiosarcoma, Adult Desmoplastic Small Round Cell Tumor Trial in Portland, Seattle

Completed
Has Results
  • Adult Alveolar Soft Part Sarcoma
  • +18 more
  • Portland, Oregon
  • +1 more
Sep 23, 2021

Solid Tumor, Adult, Brain Tumor, Primary, Desmoplastic Small Round Cell Tumor Trial in Australia, Korea, Republic of, United

Recruiting
  • Solid Tumor, Adult
  • +2 more
  • Santa Monica, California
  • +11 more
Jul 27, 2022

Desmoplastic Small Round Cell Tumor, Rhabdomyosarcoma Trial in New York (Prexasertib, Irinotecan)

Active, not recruiting
  • Desmoplastic Small Round Cell Tumor
  • Rhabdomyosarcoma
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Oct 3, 2022

Desmoplastic Small Round Cell Tumor Trial in New York

Recruiting
  • Desmoplastic Small Round Cell Tumor
    • New York, New York
      Memorial Sloan Kettering Cancer Center (All Protocol Activities)
    Jan 6, 2022

    Ewing Sarcoma, Desmoplastic Small Round Cell Tumor, Pediatric Cancer Trial in Philadelphia (Lurbinectedin)

    Not yet recruiting
    • Ewing Sarcoma
    • +3 more
    • Philadelphia, Pennsylvania
      Children's Hospital of Philadelphia
    Jun 27, 2023

    Peritoneal Cancer Trial in New York (131 I-8H9)

    Active, not recruiting
    • Peritoneal Cancer
    • 131 I-8H9
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Feb 7, 2022

    Sarcoma, Desmoplastic Small Round Cell Tumor (DSRCT) Trial in New York (irinotecan, temozolomide, and bevacizumab incorporated

    Active, not recruiting
    • Sarcoma
    • Desmoplastic Small Round Cell Tumor (DSRCT)
    • irinotecan, temozolomide, and bevacizumab incorporated into an existing schedule of high dose alkylator
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Sep 1, 2021

    Desmoplastic Small Round Cell Tumor Trial in Worldwide (Ramucirumab, Cyclophosphamide, Vinorelbine)

    Active, not recruiting
    • Desmoplastic Small Round Cell Tumor
    • Phoenix, Arizona
    • +50 more
    Jan 18, 2023

    Epithelioid Sarcoma (Ex-US Only), Spindle Cell Sarcoma, Sinonasal Carcinoma Trial (Tazemetostat)

    Temporarily not available
    • Epithelioid Sarcoma (Ex-US Only)
    • +19 more
    • (no location specified)
    Oct 17, 2022

    Pediatric Solid Tumor, Osteosarcoma, Rhabdomyosarcoma Trial in Memphis (Fludarabine, Cyclophosphamide, MESNA)

    Recruiting
    • Pediatric Solid Tumor
    • +15 more
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Jun 30, 2022

    Desmoplastic Small Round Cell Tumor, Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Desmoplastic Small

    Recruiting
    • Desmoplastic Small Round Cell Tumor
    • +11 more
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +8 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jun 26, 2022

    Pediatric Solid Tumor, Germ Cell Tumor, Retinoblastoma Trial in Seattle (second generation 4-1BB? EGFR806-EGFRt, second

    Recruiting
    • Pediatric Solid Tumor
    • +15 more
    • second generation 4-1BBζ EGFR806-EGFRt
    • second generation 4-1BBζ EGFR806-EGFRt and a second generation 4 1BBζ CD19-Her2tG
    • Seattle, Washington
      Seattle Children's Hospital
    May 2, 2022

    Ewing Sarcoma, Myxoid Liposarcoma, Desmoplastic Small Round Cell Tumor Trial in Santa Monica (Seclidemstat)

    Enrolling by invitation
    • Ewing Sarcoma
    • +8 more
    • Santa Monica, California
      Sarcoma Oncology Center
    Feb 23, 2022

    Malignant Abdominal Tumor, Malignant Pelvic Tumor, Recurrent Colon Carcinoma Trial in Rochester (Cisplatin, Cytoreductive

    Recruiting
    • Malignant Abdominal Neoplasm
    • +26 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jan 5, 2023

    Soft Tissue Sarcoma, Clear Cell Sarcoma, Epithelioid Sarcoma Trial in France (Patient with Soft Tissue Sarcoma)

    Recruiting
    • Soft Tissue Sarcoma
    • +9 more
    • Patient with Soft Tissue Sarcoma
    • Besancon, France
    • +13 more
    Oct 11, 2022

    Neuroblastoma, Rhabdomyosarcoma, Osteosarcoma Trial in United States (Enoblituzumab)

    Completed
    • Neuroblastoma
    • +5 more
    • Palo Alto, California
    • +5 more
    Feb 4, 2022

    Soft Tissue Sarcoma Adult, Undifferentiated Pleomorphic Sarcoma, Epithelioid Sarcoma Trial in Bordeaux (Trabectedin)

    Recruiting
    • Soft Tissue Sarcoma Adult
    • +6 more
    • Bordeaux, France
      Institut Bergonie
    Feb 1, 2022

    Metastatic Breast Cancer, Advanced Non-Small Cell Squamous Lung Cancer, Solid Tumor, Adult Trial (Patritumab deruxtecan)

    Not yet recruiting
    • Metastatic Breast Cancer
    • +2 more
    • Patritumab deruxtecan
    • (no location specified)
    May 9, 2023

    Unresectable Melanoma, Metastatic Melanoma, Stage III NSCLC Trial in Louisville, New York (IOV-4001)

    Recruiting
    • Unresectable Melanoma
    • +3 more
    • IOV-4001
    • Louisville, Kentucky
    • +2 more
    Nov 21, 2022

    Solid Tumor, Adult, Solid Tumor, Pancreatic Cancer Trial in United States (A2B530, xT-Onco with HLA-LOH Assay)

    Not yet recruiting
    • Solid Tumor, Adult
    • +15 more
    • A2B530
    • xT-Onco with HLA-LOH Assay
    • Duarte, California
    • +6 more
    Feb 10, 2023

    Ewing Sarcoma, Myxoid Liposarcoma, Sarcoma,Soft Tissue Trial in United States (Seclidemstat, Cyclophosphamide, Topotecan)

    Recruiting
    • Ewing Sarcoma
    • +10 more
    • Los Angeles, California
    • +16 more
    Jan 18, 2022

    NSCLC Trial (Bemcentinib, Pembrolizumab, Pemetrexed)

    Not yet recruiting
    • Carcinoma, Non-Small-Cell Lung
    • (no location specified)
    Jul 19, 2022

    Solid Tumor, Adult, NSCLC, Advanced Cancer Trial (Adagrasib, nab-Sirolimus)

    Not yet recruiting
    • Solid Tumor, Adult
    • +4 more
    • (no location specified)
    Apr 24, 2023

    Diffuse Astrocytoma, IDH-Mutant, Glioblastoma, IDH-wildtype, Brain Metastases, Adult Trial (NEO212 Oral Capsule, Ipilimumab,

    Not yet recruiting
    • Diffuse Astrocytoma, IDH-Mutant
    • +20 more
    • NEO212 Oral Capsule
    • +8 more
    • (no location specified)
    Sep 18, 2023